All the Active Ingredient Drugs
Selective Immunosuppressants. Alemtuzumab 10 mg/ml. VIAL (conc. for sol. for infus.): 1 x 12 mg.
Recom. dose is 12 mg/d admin. by IV
infus. for 2 tmt. courses. Init. tmt.
course: 12 mg/d for 5 consec. days (60
mg total dose). 2nd tmt. course: 12
mg/d for 3 consec. days (36 mg total
dose) admin. 12 mths. after the init.
Adult pts. with RRMS with active dis.
defined by clinical or imaging features.